Related Experiment Videos
Vaginal polyps and hormones--is there a link? A case series
Sandeep Sharma1, Paola Albertazzi, Ian Richmond
1Specialist Registrar (Obstetrics and Gynaecology), Bradford Royal Infirmary, Duckworth Lane, BD9 6RJ, UK. dr_sandysharma@yahoo.co.uk
Maturitas
|July 21, 2005
Summary
Fibroepithelial stromal polyps (FSP) can occur in the vagina after hysterectomy. Hormone-modulating agents like tamoxifen and tibolone may influence vaginal polyp formation, though a direct link requires further study.
Area of Science:
- Gynecologic pathology
- Endocrinology
- Oncology
Background:
- Fibroepithelial stromal polyps (FSP) are uncommon findings in the vaginal vault post-hysterectomy.
- Tamoxifen and tibolone are known to cause endometrial polyps, but their association with vaginal polyps is not well-described.
Observation:
- A case of a symptomatic FSP is presented in a patient 30 years after hysterectomy, concurrently treated with tamoxifen and tibolone.
- A review of 34 patients with surgically removed FSP was conducted over a 4-year period.
Findings:
- Hormonal influence, either endogenous or exogenous, was identified in 22 out of 34 women with FSP.
- The study suggests a potential link between gonadal hormones or hormone modulators and vaginal polyp development.
Implications:
- This research highlights a possible association between hormone-modulating therapies and vaginal polyps.
- Further investigation is needed to establish a precise contribution of specific drugs to vaginal polyp formation.